Agios Pharmaceuticals (AGIO) Leases: 2019-2025
Historic Leases for Agios Pharmaceuticals (AGIO) over the last 7 years, with Sep 2025 value amounting to $33.6 million.
- Agios Pharmaceuticals' Leases fell 26.59% to $33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year decrease of 26.59%. This contributed to the annual value of $42.9 million for FY2024, which is 21.19% down from last year.
- Per Agios Pharmaceuticals' latest filing, its Leases stood at $33.6 million for Q3 2025, which was down 8.52% from $36.8 million recorded in Q2 2025.
- In the past 5 years, Agios Pharmaceuticals' Leases ranged from a high of $82.2 million in Q1 2021 and a low of $33.6 million during Q3 2025.
- Its 3-year average for Leases is $48.5 million, with a median of $48.8 million in 2024.
- Data for Agios Pharmaceuticals' Leases shows a maximum YoY declined of 26.59% (in 2025) over the last 5 years.
- Over the past 5 years, Agios Pharmaceuticals' Leases (Quarterly) stood at $75.1 million in 2021, then dropped by 13.30% to $65.1 million in 2022, then declined by 16.46% to $54.4 million in 2023, then dropped by 21.19% to $42.9 million in 2024, then decreased by 26.59% to $33.6 million in 2025.
- Its Leases stands at $33.6 million for Q3 2025, versus $36.8 million for Q2 2025 and $39.9 million for Q1 2025.